Merck & Co Inc logo

MRK - Merck & Co Inc News Story

$79.94 -0.3  -0.4%

Last Trade - 26/02/20

Large Cap
Market Cap £157.16bn
Enterprise Value £151.06bn
Revenue £36.02bn
Position in Universe 31st / 6407

BUZZ-Moody's sees brisk deal activity for pharma, cost pressure for insurers

Thu 16th January, 2020 5:36pm
** M&A activity among pharma companies this year will follow
the brisk pace set in late 2019, Moody's Investors Service says;
names Gilead Sciences  GILD.O , Johnson & Johnson  JNJ.N  and
Merck & Co  MRK.N  among most likely acquirers 
    ** Says research-stage companies as likely targets, adding
that larger, more expensive deals involving profitable targets
are less likely, but the possibility cannot be ruled out
    ** For health insurers, the rating agency expects increased
short-term cost pressures, driven by increased use of high-cost
specialty drugs
    ** Agency says the companies best positioned to manage
specialty drugs cost are UnitedHealth Group  UNH.N  and Cigna
Corp  CI.N  , which each own pharmacy benefit managers, and CVS
Health Corp's  CVS.N  Aetna
    ** Expects the return of an industry-wide health insurance
fee (HIF), created to help fund the Affordable Care Act, to
pressure UNH, Anthem Inc  ANTM.N , Aetna and Humana Inc  HUM.N 
this year; says the companies will be the biggest beneficiaries
of the HIF elimination in 2021

 (Reporting by Manojna Maddipatla in Bengaluru)
 ((; within the U.S. +1 646
223 8780, outside the U.S. +91  80 6749 1692))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.